Nail-Biting Time for Trials of COX-2 Drugs
- 3 December 2004
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 306 (5702) , 1673-1675
- https://doi.org/10.1126/science.306.5702.1673
Abstract
Preliminary studies suggest that the COX-2 inhibitor Celebrex may stem cancer and Alzheimer's disease, but testing these possibilities has just gotten tougher.Keywords
This publication has 0 references indexed in Scilit: